FAU Awarded $2.1 Million to Study Effectiveness of Medication for Schizophrenia

FAU's Charles E. Schmidt College of Medicine was recently awarded a $2.1 million, two-year contract by Otsuka America Pharmaceutical Inc. to conduct a study to examine the effectiveness of an injectable long-acting anti... Morepsychotic medication for schizophrenia and its impact on 30-day hospital readmission rates.